LVZ, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
LVZ, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$257,043
+4.5%
3,006
+9.4%
0.04%
-10.0%
Q3 2023$246,076
-23.6%
2,747
-27.4%
0.04%
-11.1%
Q2 2023$322,0853,7830.04%
Other shareholders
HAEMONETICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders